Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Rank in Stocks #13762
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Share Price
$0.85814713
Last synced: 2025-05-14
Market Cap
$463.40M
Change (1 day)
-2.52%
Change (1 year)
0.00%
Country
GB
Trade Alliance Pharma plc (APH)

Category

Revenue for Alliance Pharma plc (APH)
Revenue in Dec 2024 TTM: $224.41M
According to Alliance Pharma plc latest financial reports the company's current revenue (TTM) is $224.41M. In 2023 the company made a revenue of $230.01M an increase over the revenue in the year 2022 that was $202.54M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Alliance Pharma plc from 2001 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $224.41M 0.00%
2024 $224.41M -2.43%
2023 $230.01M 13.56%
2022 $202.54M -8.21%
2021 $220.65M 24.34%
2020 $177.46M -1.34%
2019 $179.87M 19.46%
2018 $150.56M 7.84%
2017 $139.62M 16.04%
2016 $120.32M 68.90%
2015 $71.24M 5.03%
2014 $67.83M -10.01%
2013 $75.38M 3.50%
2012 $72.83M 2.12%
2011 $71.32M -8.14%
2010 $77.64M 53.57%
2009 $50.56M 59.16%
2008 $31.76M -12.52%
2007 $36.31M 7.34%
2006 $33.83M 60.14%
2005 $21.13M 9.03%
2004 $19.38M 44.44%
2002 $13.42M 51.66%
2001 $8.85M 0.00%
Revenue for similar companies or competitors